How to Buy Collegium Pharmaceutical Stock

Collegium Pharmaceutical Inc

Collegium Pharmaceutical, Inc. (COLL) is a specialized pharmaceutical firm dedicated to the development and marketing of medications for pain management.

Collegium Pharmaceutical stock last closed at $22.81, up 0.26% from the previous day, and has decreased 34.68% in one year. It has overperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 0.61 percentage points. Collegium Pharmaceutical stock is currently +1.38% from its 52-week low of $22.50, and -55.09% from its 52-week high of $50.79.

There are currently 32.56M COLL shares outstanding. The market capitalization of COLL is $742.59M. In the past 24 hours, 826,000 COLL shares were traded.

How to Buy Collegium Pharmaceutical Stock

Not sure how to invest in Collegium Pharmaceutical stock? Here's how.

  1. Choose where to buy Collegium Pharmaceutical stock: You need to decide on an online brokerage, but don't worry - we've analyzed dozens of online brokerages and apps to help you decide where to buy Collegium Pharmaceutical stock.
  2. Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
  3. Deposit funds into your brokerage account: Choose your payment method and add your information.
  4. Research Collegium Pharmaceutical stock: The Collegium Pharmaceutical ticker symbol is COLL. Is Collegium Pharmaceutical stock a good investment? Should you buy shares of COLL? How do COLL's underlying business fundamentals look? Do top analysts think Collegium Pharmaceutical is a good buy? Why has COLL's stock price moved recently? (Hint: Our stock research website can help you evaluate if COLL is a good stock to buy).
  5. Execute your COLL trade: Decide if you will purchase COLL shares at the current market price or use a limit order to purchase COLL stock at a specific price.
  6. Track your investment in COLL: Create a watchlist to get the latest news on your position in Collegium Pharmaceutical stock.

Step 1: Choose where to buy Collegium Pharmaceutical stock

You need an online brokerage account to access the NASDAQ market and buy COLL stock.

A brokerage account is an investment account that enables you to buy and sell a number of investments, including stocks, bonds, mutual funds, and ETFs.

Our preferred brokerage: eToro

In our opinion, eToro is the best brokerage. eToro gives you:

  • Invest in stocks with zero commissions: Invest without paying trading commissions.
  • Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
  • Access to global financial markets: From Technology to Industrials, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top stock exchanges.
  • Social investing: eToro boasts a community with more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
  • Security: eToro is a regulated and licensed fintech leader.
  • Buy other financial assets: Such as ETFs and cryptocurrencies.

Get $10 towards your purchase of shares by creating an account with eToro now. This offer is only for US users.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Sign up for your brokerage account

Now that you've picked the best brokerage, you need to fill out some personal details so you are able to invest in COLL stock today.

How to Create a New Brokerage Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Input your personal info to start a new trading account.
  1. Send your data by pressing the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Deposit funds into your brokerage account

Now that you've filled out your info on the best stock app, you need to deposit funds:

Check out the walkthrough below to see the process of transferring money into your new investment account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Research Collegium Pharmaceutical stock

After you have chosen the best place to buy Collegium Pharmaceutical stock, it's crucial to analyze their stock prior to buying, so you can wrap your head around the risk as well as the upside.

Collegium Pharmaceutical quick stats

COLL Price
$22.81
1w %
-2.4%
1y %
-34.68%
5y %
14.51%
P/E
15.01x
P/B
2.38x
P/S
0.92x
PEG
0.23x
Revenue
$808.21M
Earnings
$47.92M
Fore. Rev. Growth
2.92%
Fore. Earn. Growth
63.89%
Market Cap
$742.59M
Next Earnings
Nov 5, 2026
Next Dividend
N/A

Fundamentals of COLL

WallStreetZen was built to help everyday investors do more accurate fundamental analysis.

You can see all of the due diligence checks on COLL's stock page.

Is COLL stock properly valued?

You can use many financial metrics, analyses, models, and charts to gauge COLL's intrinsic value.

Using relative valuations methods:

  • COLL may be overvalued based on its P/E ratio of 15.01x, relative to Drug Manufacturers - Specialty & Generic industry P/E ratio of 2.81x
  • COLL may be overvalued based on its P/B ratio of 2.38x, relative to Drug Manufacturers - Specialty & Generic industry P/B ratio of 2.36x
  • COLL could be undervalued based on its PEG ratio of 0.23x

You can access more valuation research on COLL's stock here.

How do COLL Financials look?

Signs that COLL is financially healthy:

  • There are more short-term assets than short-term liabilities on the COLL balance sheet.
  • COLL's operating cash flow of $329.92M allows it to safely service it's debt of $1.10B.
  • COLL profit margin has gone up from 5.1% to 5.9% in the past year.

Signs that COLL is not financially healthy:

  • COLL has a relatively high debt to equity ratio of 5.85.
  • There are more long-term liabilities than short-term assets on the COLL balance sheet.
  • Total COLL debt is higher than 5 years ago, relative to shareholder equity.
  • COLL earnings of $154.12M is not enough to cover its interest payments.

Do Wall Street analysts think it's a good time to buy Collegium Pharmaceutical stock

Out of 6 Equities analysts who give ratings on COLL, the consensus analyst rating on COLL is a Buy

It's important to note that analyst ratings are not stock recommendations, nor are they financial advice.

Latest COLL Analyst Upgrades/Downgrades

Brandon Folkes, a top 27% analyst from HC Wainwright & Co. reiterates COLL with a buy rating and maintains their COLL price target from $60.00 to $60.00, on Mar 20, 2026.

You can dig deeper into what analysts are projecting on the Collegium Pharmaceutical stock forecast page.

COLL Trading Indicators

SMA10
23.54
SMA20
25.47
SMA50
30.52
SMA100
32.41
SMA200
37.51
MACD
-2.17
MACD Signal
-2.17
MACD Histogram
0
RSI
22.81
Stochastic %K
3.66
Stochastic %D
3.71
StochRSI %K
1.76
StochRSI %D
0.59

COLL Growth Numbers

Last year, COLL earnings were $47.92M. During the last 5 year, COLL's earnings have gone up by -12.94% per year. This was slower than the Drug Manufacturers - Specialty & Generic industry average of 6.7%.

Last year, COLL revenue was $808.21M. During the past 5 year, COLL's revenue has increased by 19.9% per year. This was faster than the Drug Manufacturers - Specialty & Generic industry average of 9.2%.

Find out more about COLL's earnings and revenue performance here.

Who is buying/selling COLL?

Over the last year, executives and large shareholders at COLL have sold more shares than they have bought.

Gino Santini, Director of COLL, was the latest COLL insider to buy. They bought $143,463.00 worth of COLL stock on Jun 8, 2026.

Get more info about who owns COLL shares here.

Can I rely on COLL as an income stream?

No, Collegium Pharmaceutical doesn't provide an income stream by paying out dividends.

What others are saying about COLL

One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.

Click below to find out what other traders have to say.

Step 5: Execute your COLL trade

There are two main options:

  • Market order: A market order is an order to buy or sell a stock at the best price on the market.
    Market orders are usually fine for most investors.
  • Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
    If you want to be certain you're buying or selling at an exact dollar amount limit, place a limit order.

Hit the Open Trade button and eToro will place the order.

If you require more info about investing in stocks on eToro, click the helpful video below:

Open eToro Account

Step 6: Track your investment in COLL

Now that you own some shares in COLL, you'll want to keep up with your new shares.

Put COLL on a watchlist to keep tabs on your COLL stock.

COLL Feed

How to Buy Stock in Collegium Pharmaceutical

To reiterate, here are the 6 steps to buy Collegium Pharmaceutical stock:

  1. Choose where to buy Collegium Pharmaceutical stock
  2. Sign up for your brokerage account
  3. Deposit funds into your brokerage account
  4. Research Collegium Pharmaceutical stock
  5. Execute your COLL trade
  6. Track your investment in COLL

If you are looking for a brokerage account, eToro is our recommended option.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you would like to track your new investment in Collegium Pharmaceutical, get started below.

NASDAQ: COLL
$22.81+0.06 (+0.26%)
Updated Sep 14, 2026
Open eToro Account
Your capital is at risk.
NASDAQ: COLL
$22.81+0.06 (+0.26%)
Updated Sep 14, 2026
Open eToro Account
Your capital is at risk.

FAQ

How much does it cost to buy one Collegium Pharmaceutical share?

As of Sep 14, 2026, it costs $22.81 to buy one share of Collegium Pharmaceutical stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.438 shares of COLL.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Collegium Pharmaceutical stock?

According to 6 Wall Street analysts who monitor Collegium Pharmaceutical, their consensus recommendation is to buy Collegium Pharmaceutical stock.

What is the best way to buy Collegium Pharmaceutical stock?

One way to place an order for Collegium Pharmaceutical stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.